| Margaret Layton Phillips, MSOT, OTR/L | |
|
127 Midway St Apt A, Cadiz, KY 42211-6142 | |
| (270) 350-2042 | |
| Not Available |
| Full Name | Margaret Layton Phillips |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 127 Midway St Apt A, Cadiz, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750145447 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 288667 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Margaret Layton Phillips, MSOT, OTR/L 127 Midway St Apt A, Cadiz, KY 42211-6142 Ph: (270) 350-2042 | Margaret Layton Phillips, MSOT, OTR/L 127 Midway St Apt A, Cadiz, KY 42211-6142 Ph: (270) 350-2042 |
News Archive
Spinal Restoration, Inc. announced today that patient enrollment in the company's Phase III study of the Biostat System for the treatment of discogenic chronic low back pain is now underway. The study, which will be conducted at 15 U.S. clinical sites, is one of only a few multi-center, randomized, blinded, placebo-controlled trials of a nonsurgical treatment for discogenic low back pain ever to be conducted.
A team of researchers in the Perelman School of Medicine at the University of Pennsylvania, Case Western Reserve University, Cleveland Clinic, and Cedars-Sinai Medical Center, were recently awarded a $3.2 million grant from the National Institutes of Health to enhance research for improving heart transplant outcomes for patients.
Repligen Corporation today announced that it has received a Complete Response Letter (CRL) from the U.S. Food & Drug Administration (FDA) regarding the Company's New Drug Application (NDA) for RG1068.
Onyx Pharmaceuticals, Inc. today announced updated interim results of the Phase 1b dose-escalation trial, known as the 006 study, evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed and/or refractory myeloma. These data are being presented today at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
› Verified 4 days ago
Mrs. Marsha Dawn Spain, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2582 Cerulean Rd, Cadiz, KY 42211 Phone: 270-522-3236 Fax: 270-522-0825 | |
Mrs. Karen Eileen Miracle, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 169 Robert Mitchell Rd, Cadiz, KY 42211 Phone: 270-522-1220 | |
Miss Shelby Paige Stevens, OTR/L, MSOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 254 Main St, Cadiz, KY 42211 Phone: 270-350-1298 | |
Mary Elizabeth Collier, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 72 Lone Oak Dr, Cadiz, KY 42211 Phone: 270-522-0488 |